BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRO/CMO), will deliver a webinar presentation followed by an interactive discussion session.
|
FREE WEBINAR: |
Bioavailability Challenge 2013 – A Virtual Event |
|
|
March 20, 2013 |
||
|
11:20 PDT/2:20 EDT |
||
|
TOPIC: |
|
“Solubilization: Potential Impact on the Pharmaceutical Industry” |
| -- Trends in drug discovery and development | ||
| -- Impact of insolubility on marketed and potential drugs | ||
| -- Opportunity created by overcoming bioavailability challenges with novel approaches | ||
| -- Leveraging fundamental science and automation to enable exploration of a new chemical space | ||
|
WHO: |
Marshall Crew, Ph.D., President and CEO, Agere | |
| Sanjay Konagurthu, Ph.D., Senior Director of Formulation Science, Agere |
To register, please follow this link: https://events.wavecastpro.com/BioavailabilityChallenge2013?utm_source=SabOSPNL&utm_medium=SpecialAlertBar&utm_campaign=AttBAC13
About Agere
Agere is a leading CRO/CMO focused on improving the oral bioavailability of insoluble APIs. The company supports clients from formulation design and development through cGMP manufacturing for Phase I through Phase IIb clinical trials. Agere is expert in solid dispersion techniques including spray drying and hot melt extrusion (HME), and in a broad selection of solid dosage forms. All services are delivered on a fee-for-service basis, and every project the company undertakes is customized to serve each client’s requirements. Agere is located in Bend, OR. For information: www.agerepharma.com.